{"id":"W2031747016","doi":"10.1517/14712598.2014.922535","title":"Obinutuzumab for B-cell malignancies","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Chronic lymphocytic leukemia; Lymphoma; Oncology; Monoclonal antibody; Immunology; Internal medicine; Antibody; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005386618,0.0006742411,0.002554207,0.0001744729,0.0001262327,0.00003919429,0.0004886766,0.001060211,0.0004613841],"category_scores_gemma":[0.000260468,0.0003582616,0.001301457,0.0002312645,0.0002261018,0.0000196498,0.00008601989,0.0004455209,0.0004453225],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007117409,"about_ca_system_score_gemma":0.00366757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001569641,"about_ca_topic_score_gemma":8.032697e-8,"domain_scores_codex":[0.9969162,0.0003132917,0.0007213866,0.0009457649,0.0003945626,0.0007087751],"domain_scores_gemma":[0.9971483,0.001352535,0.0002491648,0.0008656205,0.0001127797,0.0002715706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004998417,0.0002503616,1.043079e-7,0.001045976,0.0001248163,0.000009509633,0.00002959384,1.184819e-7,0.00002875454,0.0008673259,0.0243398,0.9728038],"study_design_scores_gemma":[0.008241779,0.004030417,2.579469e-7,0.004312147,0.000002536513,0.00008423521,0.000009696627,0.00003276828,0.0001092031,0.0000750757,0.9826802,0.0004216689],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001174359,0.9933545,0.0001644332,0.0001357348,0.000876321,0.003277965,0.00003634616,0.0001690258,0.001973927],"genre_scores_gemma":[0.000016427,0.9924228,0.0006256041,0.001538801,0.002268947,0.001686193,0.0006690048,0.00009794573,0.0006742951],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9723821,"threshold_uncertainty_score":0.9998869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2552297063283639,"score_gpt":0.4601535520919414,"score_spread":0.2049238457635775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}